Scitex Announces Second Quarter 2004 Results

Name	Symbol	Market	Type
Global X Scientific Beta Asia ex Japan ETF	AMEX:SCIX	AMEX	Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.00	0.00%	21.115				0	01:00:00

Global X Scientific Beta... (AMEX:SCIX)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Global X Scientific Beta... Charts.

Scitex Announces Second Quarter 2004 Results Scitex Vision achieves record quarterly revenues in excess of $30 million TEL AVIV, Israel, August 3 /PRNewswire-FirstCall/ -- Scitex Corporation Ltd. (NASDAQ:SCIX)(TASE:SCIX) today announced its unaudited financial results for the second quarter ended June 30, 2004. Results of Operations For the second quarter of 2004, Scitex's revenues were $30.8 million, an increase of 25.2% from $24.6 million in the second quarter of 2003. Operating income was $0.2 million compared to an operating loss of $2.2 million in the second quarter of 2003. Net loss for the second quarter of 2004 was $1.2 million compared to a net loss of $4.8 million in the second quarter of 2003. Raanan Cohen, Interim President and CEO of Scitex, commented: "I am pleased with the performance of our principal operating subsidiary, Scitex Vision, achieving a sixth consecutive quarter of revenue growth, with record revenue of over $30 million, net income of $1.2 million and positive cash flow. During the quarter, Scitex Vision strengthened its leadership in the wide and super-wide format graphic arts markets, and its diversified product offering and advanced technologies attracted substantial attention and business at the May 2004 DRUPA trade fair in Germany. I congratulate management and employees of Scitex Vision for the impressive results." Balance Sheet Scitex's cash, cash equivalents and short-term investments at the end of the second quarter of 2004, on a consolidated basis, were $234.0 million (excluding a restricted deposit of $18.1 million). This amount gives effect to the approximately $28 million repurchase of shares by Scitex in the self tender offer that was completed in June 2004; however the approximately $90.0 million cash distribution being effected in the third quarter of 2004 is not reflected in said item. Scitex's cash, cash equivalents and short-term investments balance is expected to be approximately $135 million, excluding $10 million retained in custodial accounts in connection with the transaction to sell the business of SDP to Eastman Kodak Company that was completed in January 2004, and after giving effect mainly to the approximately $90 million cash distribution and to the estimated remaining tax payments relating to U.S. federal income tax audit of Scitex's U.S. subsidiaries for the years 1992 through 1996. Trade receivables at the end of the second quarter of 2004 increased to $36.8 million from $36.0 million at the end of 2003, and inventory increased to $27.1 million from $22.6 million, both primarily as a result of the increase in revenues and business activities. Scitex Vision The second quarter of 2004 continues the solid quarter-to-quarter revenue growth demonstrated by Scitex Vision since the beginning of 2003. During the quarter, Scitex Vision's sales of its various product lines were characterized by continuing demand for the XLjet and Grandjet super wide-format digital presses and sales of several wide-format Turbojet presses that were introduced in late 2003. Solid growth in ink sales reflecting stable Scitex Vision market share and increasing consumption by its customers also contributed to the increase in revenues compared to the previous quarters. Scitex Vision's revenues for the second quarter of 2004 were $30.8 million, an increase of 25.2% from $24.6 million in the corresponding quarter of 2003 and an increase of 5.5% from $29.2 million in the first quarter of 2004. Scitex Vision had operating income of $2.0 million in the second quarter of 2004, compared to an operating loss of $1.2 million in the second quarter of 2003, and operating income of $2.6 million in the first quarter of 2004. Scitex Vision had net income of $1.2 million in the second quarter of 2004, compared to a net loss of $2.9 million in the second quarter of 2003, and net income of $2.1 million in the first quarter of 2004. The decrease in operating and net income compared to the prior quarter is mainly attributable to the expenses relating to three major international trade shows in which Scitex Vision participated during the second quarter. Scitex Vision's geographic distribution of business this quarter was led by Europe, contributing 46% of revenues, followed by the Americas with 32% of revenues, and the rest of the world (primarily the Far East) with 22% of revenues. Conference Call Scitex will be holding a conference call to discuss its second quarter 2004 results on Wednesday, August 4, 2004 at 10:00 a.m. EST (7:00 a.m. Pacific time, 3:00 p.m. London, 5:00 p.m. Israel). All interested parties will have the opportunity to listen to a live simultaneous Webcast of the conference call by connecting online through http://www.scitex.com/. A replay of the conference call will be available shortly after the call during the seven days following the conference call (until midnight August 11, 2004) at the following numbers: US: 1 800 475-6701 Intl: 1 320 365-3844 Access code: 739941 Scitex Corporation Ltd. Scitex Corporation Ltd's shares trade on Nasdaq and The Tel Aviv Stock Exchange under the symbol "SCIX". For more information, please visit our Web site at http://www.scitex.com/. Forward Looking Statements Except for the historical information herein, the matters discussed in this news release include forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements that are based on various assumptions (some of which are beyond the Company's control) may be identified by the use of forward-looking terminology, such as "may", "can be", "will", "expects", "anticipates", "intends", "believes", "projects", "potential", "are optimistic", "view" and similar words and phrases. Actual results could differ materially from those set forth in forward-looking statements due to a variety of factors, including, but not limited to, (1) risks in product and technology development, (2) market acceptance of new products and continuing product demand, (3) the impact of competitive products and pricing, (4) changes in domestic and foreign economic and market conditions, (5) timely development and release of new products by strategic suppliers, (6) the impact of the Company's accounting policies, (7) risks relating to the integration of new businesses, (8) uncertainty of outcome of shareholder litigation, and (9) the other risk factors detailed in the Company's most recent annual report and other filings with the US Securities and Exchange Commission. Except as may be required by law, the Company does not undertake, and specifically disclaims, any obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such forward-looking statements. Scitex and the Scitex logo are registered trademarks and registered service marks of Scitex Corporation Ltd. Contacts Scitex Corporation Ltd. Yahel Shachar Chief Financial Officer Tel: +972-3-607-5855 Fax: +972-3-607-5884 E-mail: SCITEX CORPORATION LTD. (AN ISRAELI CORPORATION) AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (U.S. Dollars in thousands, except per share data) Quarter ended June, 30 2004 2003 (Unaudited) (Unaudited) Revenues Sales $ 18,886 $ 13,583 Service and supplies 11,910 11,042 Total revenues 30,796 24,625 Cost of revenues Cost of sales 11,029 8,032 Cost of service and supplies 6,260 7,127 Total cost of revenues 17,289 15,159 * Gross profit 13,507 9,466 Expenses Sales and marketing 5,431 4,549 * General & administrative 4,065 3,312 Research and development, net 2,326 2,396 Amortization of intangible assets 1,523 1,370 Operating income (loss) 162 (2,161) Financial expense - net (233) (1,389) Other expenses - net (489) (3,293) Loss before taxes on income (560) (6,843) Taxes on income (124) (380) (684) (7,223) Share in losses of associated companies (250) (1,056) Minority interest in losses (income) of a subsidiary (224) 735 Net loss from continuing operations (1,158) (7,544) Net income (loss) from discontinued operation (78) 2,704 Net loss ($ 1,236) ($ 4,840) Loss per share - basic and diluted: continuing operations ($ 0.03) ($ 0.17) discontinued operation ($ 0.002) $ 0.06 Weighted average number of shares outstanding (in thousands) basic and diluted: 42,193 43,018 * Reclassified CONSOLIDATED BALANCE SHEETS (U.S. Dollars in thousands) June 30 December 31 2004 2003 (Unaudited) (Audited) Assets Current assets: Cash and cash equivalents $ 178,550 $ 52,861 Short-term investments 55,437 8,235 Restricted deposits 18,050 18,262 Total cash and short-term investments 252,037 79,358 Trade receivables - net 36,843 36,002 Other receivables 10,832 6,990 * Inventories 27,087 22,575 Current assets of discontinued operation 0 161,602 326,799 306,527 Investments and other non-current assets 14,174 6,781 Property plant and equipment - net 9,231 9,204 Goodwill and other intangible assets - net 23,615 23,499 Non-Current assets of discontinued operation 0 48,897 $ 373,819 $ 394,908 *Reclassified Liabilities and Shareholders' Equity Current liabilities: Short term debt and current maturities $ 36,199 $ 47,953 Trade payables 18,461 14,505 Taxes on income, net of advances 18,660 29,517 Accrued and other liabilities 27,008 22,672 * Cash distribution payable to shareholders 89,837 Current liabilities related to discontinued operation 6,968 31,935 197,133 146,582 Long-term liabilities: Loans from banks 5,926 6,623 Loans from other 4,256 3,623 Liability for employee rights upon retirement 3,550 3,022 Long-term liabilities related to discontinued operation 0 5,431 13,732 18,699 Loans from related parties, convertible into subsidiary's shares 1,472 756 Minority interest 4,955 4,173 217,292 170,210 Shareholders' equity: Share capital 6,205 6,205 Capital surplus 278,267 368,104 Accumulated other comprehensive income (loss) 154 (552) Accumulated deficit (95,799) (144,852) Treasury shares, at cost (32,300) (4,207) 156,527 224,698 $ 373,819 $ 394,908 *Reclassified Scitex Vision Ltd. US Dollar in Thousands Three months ended June, 30 2004 2003 Unaudited Unaudited Revenues Equipment 18,886 13,583 Service and Consumables 11,910 11,042 Total Revenues 30,796 24,625 Gross Profit 13,507 9,466 * Expenses: S,G&A 8,700 7,196 * Research and Development 1,891 2,396 Amortization of Intangibles 932 1,083 11,523 10,675 Operating (Loss) Income 1,984 (1,209) Financial expenses (651) (1,385) Other Income (expenses) (39) 41 Tax on Income (102) (380) Net Income (Loss) 1,192 (2,933) * Reclassified DATASOURCE: Scitex Corporation Ltd CONTACT: Contacts: Scitex Corporation Ltd. Yahel Shachar, Chief Financial Officer, Tel: +972-3-607-5855 Fax: +972-3-607-5884 E-mail:

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SCIX Global X Scientific Beta Asia ex Japan ETF